cannabis indica

Síndrome da Hiperêmese Canabinoide

termo de indexação original: Cannabis Hyperemesis Syndrome

O acervo do Cannabis Indica reúne 184 estudos científicos que tocam a condição Síndrome da Hiperêmese Canabinoide, publicados entre 2004 e 2024. Pela leitura automatizada, 19 (10%) foram classificados como favoráveis, 44 (24%) como inconclusivos e 121 (66%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (176 estudos), seguido de ensaio clínico (4). Os compostos mais presentes são Capsaicina (CAPS), THC Farmacêutico e Tetraidrocanabinol (THC). Aparece com frequência ao lado de Náusea e Vômito, Efeitos Adversos da Cannabis e Dor.

Estudos indexados
184
Período coberto
2004–2024
Favoráveis
19 · 10%
Inconclusivos
44 · 24%
Desfavoráveis
121 · 66%
Termo original
Cannabis Hyperemesis Syndrome

O acervo em números

Tipo de estudo

Metanálise176
Ensaio Clínico4
Ensaio Clínico Duplo-Cego3
Metanálise Clínica1

Direção do resultado

Favorável19
Inconclusivo44
Desfavorável121

Por década

2000s5
2010s102
2020s77

184 estudos

Filtrar e buscar no acervo →
  1. 2024

    Acute and Long-Term Effects of App-Delivered Heartfulness Meditation on Psychological Outcomes and the Endocannabinoid Signaling System in Cyclic Vomiting Syndrome

    FavorávelEnsaio ClínicoNáusea e VômitoAnandamida (AEA)Palmitoiletanolamida (PEA)+1
  2. 2024

    AGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisNáusea e Vômito
  3. 2024

    Cannabis induced gastrointestinal tract symptoms in the adult population: a systematic review

  4. 2024

    Cyclic vomiting syndrome: Future clinical and research priorities for: Special supplement/proceedings of 3rd international symposium

    DesfavorávelMetanáliseNáusea e VômitoEndocanabinoide (não especificado)
  5. 2024

    Distinguishing Clinical Features of Cannabinoid Hyperemesis Syndrome and Cyclic Vomiting Syndrome: A Retrospective Cohort Study

    InconclusivoMetanáliseEfeitos Adversos da CannabisNáusea e Vômito
  6. 2024

    Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue

    FavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+2
  7. 2023

    A Case of a Patient With Cannabis Hyperemesis Syndrome Along With Recurrent Nephrolithiasis

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da Cannabis+7
  8. 2023

    A Case of Cannabinoid Hyperemesis Syndrome and Acute Kidney Injury: A Review of the Literature

    DesfavorávelMetanáliseEfeitos Adversos da CannabisNáusea e Vômito
  9. 2023

    A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy

    DesfavorávelMetanáliseEfeitos Adversos da CannabisEpilepsiaNáusea e Vômito+3
  10. 2023

    Cannabinoid Hyperemesis Syndrome in a 23-Year-Old Woman with Uncontrolled Type 1 Diabetes Mellitus

  11. 2023

    Late Onset Diaphragmatic Hernia: A Forgotten Etiology of Recurrent Vomiting in the Adolescent Population

    DesfavorávelMetanáliseDorNáusea e VômitoDiabetes
  12. 2023

    Molecular Insights into GPCR Mechanisms for Drugs of Abuse

  13. 2023

    Recurrent Severe Burns Due to Cannabinoid Hyperemesis Syndrome

  14. 2023

    Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder

  15. 2022

    A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong

  16. 2022

    Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department

  17. 2022

    Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisCOVID-19
  18. 2022

    Cannabinoid hyperemesis syndrome: A 6‐year audit of adult presentations to an urban district hospital

    InconclusivoMetanálise
  19. 2022

    Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study

  20. 2022

    Case report: A case of undiagnosed cannabinoid hyperemesis syndrome in rural part of Nepal

    DesfavorávelMetanáliseEfeitos Adversos da CannabisNáusea e Vômito
  21. 2022

    Case Report: Superior Mesenteric Artery Syndrome in an Adolescent With Cannabinoid Hyperemesis

    DesfavorávelMetanáliseDorDor — Crônica
  22. 2022

    Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  23. 2022

    Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+7
  24. 2022

    Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes

    InconclusivoMetanáliseEfeitos Adversos da CannabisDiabetesSíndrome Metabólica
  25. 2022

    Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap

  26. 2022

    Herbal Approaches to Pediatric Functional Abdominal Pain

    InconclusivoMetanáliseDorInflamaçãoDor — CrônicaTHC Farmacêutico+10
  27. 2022

    Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature

    DesfavorávelMetanáliseEfeitos Adversos da CannabisNáusea e Vômito
  28. 2022

    Pneumomediastinum and Pneumorrhachis Associated With Cannabinoid Hyperemesis Syndrome

  29. 2022

    Pneumopericardium, Epidural Pneumatosis, and Muscular Emphysema: Rare Complications of Spontaneous Pneumomediastinum Due to Refractory Hyperemesis Gravidarum

    DesfavorávelMetanáliseEfeitos Adversos da CannabisNáusea e VômitoGestação+1
  30. 2022

    Shifting the Paradigm on Cannabis Safety

    DesfavorávelMetanáliseCâncerInflamaçãoEfeitos Adversos da CannabisCBD Farmacêutico+16
  31. 2022

    The Nose Knows: Aroma, but Not THC Mediates the Subjective Effects of Smoked and Vaporized Cannabis Flower

    FavorávelEnsaio ClínicoDorInflamaçãoDependência — Cannabis+1
  32. 2022

    TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

  33. 2022

    Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome

  34. 2021

    A primer on medicinal cannabis safety and potential adverse effects

  35. 2021

    A Reason to Rethink Fasting Guidelines? Marijuana-Induced Gastroparesis and the Implications for Aspiration Risk in the Nil Per Os (NPO) Patient: A Case Report

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisNáusea e Vômito+1
  36. 2021

    A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options

  37. 2021

    Adolescent Cannabis Hyperemesis Syndrome During the COVID-19 Pandemic

    DesfavorávelMetanáliseEfeitos Adversos da CannabisCOVID-19
  38. 2021

    Adverse events of recreational cannabis use reported to the French addictovigilance network (2012-2017)

    DesfavorávelMetanáliseCâncerEfeitos Adversos da CannabisDependência — Cannabis+4
  39. 2021

    Cannabinoid hyperemesis syndrome can be relieved by warm baths

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDependência — Cannabis+2
  40. 2021

    Cannabinoid Hyperemesis Syndrome in an Athlete

    DesfavorávelMetanálise
  41. 2021

    Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem

    DesfavorávelMetanálise
  42. 2021

    Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use

  43. 2021

    Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation

    DesfavorávelMetanálise
  44. 2021

    Cannabinoid Hyperemesis Syndrome: A Case Study in a Tunisian Young Man

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisNáusea e Vômito
  45. 2021

    Cannabis hyperemesis syndrome: Incidence and treatment with topical capsaicin

    FavorávelMetanáliseEfeitos Adversos da CannabisCapsaicina (CAPS)
  46. 2021

    Death of a young woman with cyclic vomiting: a case report

  47. 2021

    Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department

    FavorávelEnsaio ClínicoDorNáusea e VômitoDor — AgudaCapsaicina (CAPS)
  48. 2021

    Efficacy of topical capsaicin for the treatment of cannabinoid hyperemesis syndrome: A retrospective cohort study

    InconclusivoMetanáliseCapsaicina (CAPS)
  49. 2021

    Fool’s gold: diseased marijuana and cannabis hyperemesis syndrome

    InconclusivoMetanálise
  50. 2021

    Hot-Water Bathing Improves Symptoms in Patients with Cyclic Vomiting Syndrome and Is Modulated by Chronic Cannabis Use

    DesfavorávelMetanálise
  51. 2021

    Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDependência QuímicaEfeitos Adversos da Cannabis+2
  52. 2021

    QTc prolongation in cannabis hyperemesis syndrome patients exposed to antiemetics: A retrospective chart review

    InconclusivoMetanáliseDoenças Cardiovasculares (DCV)Arritmias Cardíacas
  53. 2021

    Response to 'Fool’s gold: diseased marijuana and cannabis hyperemesis syndrome'

    InconclusivoMetanálise
  54. 2021

    Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

  55. 2021

    Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis

    FavorávelMetanáliseEfeitos Adversos da CannabisCapsaicina (CAPS)
  56. 2021

    Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department

    InconclusivoEnsaio ClínicoCapsaicina (CAPS)
  57. 2020

    A patient with acute abdominal pain and vomiting due to the cannabinoid hyperemesis syndrome

    DesfavorávelMetanálise
  58. 2020

    A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome

    FavorávelEnsaio Clínico Duplo-CegoDorNáusea e VômitoDor — AgudaCapsaicina (CAPS)+1
  59. 2020

    Asymptomatic pneumopericardium in a young male cannabis smoker

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  60. 2020

    Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review

    DesfavorávelMetanálise
  61. 2020

    Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort

    DesfavorávelMetanálise
  62. 2020

    Cannabinoid Hyperemesis Syndrome: A Case Report and Discussion Regarding Patients with Concurrent Disorders

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDepressão+9
  63. 2020

    Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisNáusea e Vômito
  64. 2020

    Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms

    DesfavorávelMetanálise
  65. 2020

    Cannabinoid Hyperemesis Syndrome: An Unexpected Problem in an Unusual Setting-A Case Report

    DesfavorávelMetanálise
  66. 2020

    Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management

    DesfavorávelMetanálise
  67. 2020

    Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome

    DesfavorávelMetanálise
  68. 2020

    Cannabis hyperemesis syndrome: an update on the pathophysiology and management

    DesfavorávelMetanálise
  69. 2020

    Diagnosis and Acute Management of Adolescent Cannabinoid Hyperemesis Syndrome: A Systematic Review

    DesfavorávelMetanálise
  70. 2020

    Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department

    FavorávelMetanálise
  71. 2020

    Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update

    DesfavorávelMetanálise
  72. 2020

    Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin

    FavorávelMetanáliseCapsaicina (CAPS)
  73. 2020

    Patterns of Cannabis Use in Patients With Cyclic Vomiting Syndrome

    InconclusivoMetanálise
  74. 2020

    Pediatric Cannabinoid Hyperemesis: A Single Institution 10-Year Case Series

    DesfavorávelMetanálise
  75. 2020

    Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Symptoms of Nausea and Vomiting Induced by Chemotherapy

    FavorávelMetanálise ClínicaNáusea e VômitoTetraidrocanabinol (THC)THC Farmacêutico+3
  76. 2020

    Small bowel intussusception in marijuana users

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+6
  77. 2020

    Topical Capsaicin for Treating Cannabinoid Hyperemesis Syndrome

    FavorávelMetanáliseCapsaicina (CAPS)
  78. 2019

    “Cannabis hyperemesis” causation questioned

    InconclusivoMetanálise
  79. 2019

    Burden of Comorbidities in Hospitalizations for Cannabis Use-associated Intractable Vomiting during Post-legalization Period

    InconclusivoMetanáliseEfeitos Adversos da CannabisÁcido Canabicromênico (CBC-a)
  80. 2019

    Burden of Persistent Vomiting With Cannabis Use Disorder: Report From 55,549 Hospitalizations in the United States

    DesfavorávelMetanáliseDependência — CannabisNáusea e Vômito
  81. 2019

    Cannabinoid hyperemesis syndrome: A case study and discussion

    InconclusivoMetanálise
  82. 2019

    Cannabinoid hyperemesis syndrome: a review of the literature

    InconclusivoMetanálise
  83. 2019

    Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting

    DesfavorávelMetanálise
  84. 2019

    Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases

    DesfavorávelMetanálise
  85. 2019

    Cannabinoid toxicity in pediatrics

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDisfunção Cognitiva
  86. 2019

    Cannabis hyperemesis syndrome

    DesfavorávelMetanálise
  87. 2019

    Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review

    DesfavorávelMetanálise
  88. 2019

    Cannabis hyperemesis syndrome: still under recognised after all these years

    DesfavorávelMetanálise
  89. 2019

    Cannabis hyperemesis syndrome: still under recognized after all these years

    InconclusivoMetanálise
  90. 2019

    Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department

    FavorávelMetanáliseCapsaicina (CAPS)
  91. 2019

    Emergency Department and Radiological Cost of Delayed Diagnosis of Cannabinoid Hyperemesis

    DesfavorávelMetanálise
  92. 2019

    Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome

    InconclusivoMetanálise
  93. 2019

    Erythema ab igne as a complication of cannabinoid hyperemesis syndrome

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  94. 2019

    Hair cannabinoid concentrations in emergency patients with cannabis hyperemesis syndrome

    InconclusivoMetanálise
  95. 2019

    Heavy Cannabis Use Associated with Wernicke's Encephalopathy

    InconclusivoMetanálise
  96. 2019

    Recent trends in cyclic vomiting syndrome-associated hospitalisations with liberalisation of cannabis use in the state of Colorado

    DesfavorávelMetanáliseNáusea e Vômito
  97. 2019

    Recurrent Nausea and Vomiting in a Pregnant Woman with Chronic Marijuana Use

    DesfavorávelMetanálise
  98. 2019

    Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series

    InconclusivoMetanálise
  99. 2019

    Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome

    InconclusivoMetanáliseNáusea e VômitoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  100. 2019

    Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome

    DesfavorávelMetanálise
  101. 2019

    Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin

    DesfavorávelMetanáliseCapsaicina (CAPS)
  102. 2019

    The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome

    InconclusivoMetanálise
  103. 2019

    Use of Cannabis in Gastroenterological and Hepatic Disorders

  104. 2018

    A case of cannabinoid hyperemesis syndrome with Heliobacter pylori and preeclampsia during pregnancy

    DesfavorávelMetanáliseGestação
  105. 2018

    Cannabinoid hyperemesis syndrome

    DesfavorávelMetanáliseTetraidrocanabinol (THC)
  106. 2018

    Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice

    DesfavorávelMetanálise
  107. 2018

    Cannabinoid Hyperemesis Syndrome Masquerading as Uremia: An Educational Case Report.

    InconclusivoMetanálise
  108. 2018

    Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicenter retrospective chart review in a major urban area

    InconclusivoMetanálise
  109. 2018

    Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department

    DesfavorávelMetanálise
  110. 2018

    Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment

    DesfavorávelMetanáliseCapsaicina (CAPS)
  111. 2018

    Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline

    DesfavorávelMetanálise
  112. 2018

    Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review

    InconclusivoMetanálise
  113. 2018

    The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana Smokers in an Urban Public Hospital

    InconclusivoMetanálise
  114. 2017

    Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment

    DesfavorávelMetanáliseNáusea e Vômito
  115. 2017

    Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?

    InconclusivoMetanálise
  116. 2017

    Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review

    InconclusivoMetanálise
  117. 2017

    Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network

    DesfavorávelMetanálise
  118. 2017

    Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series

    DesfavorávelMetanáliseCapsaicina (CAPS)
  119. 2017

    Coronary vasospasm complicating cannabinoid hyperemesis syndrome

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)
  120. 2017

    Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?

    InconclusivoMetanáliseNáusea e Vômito
  121. 2017

    Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review

    DesfavorávelMetanálise
  122. 2017

    Propranolol Treatment of Cannabinoid Hyperemesis Syndrome: A Case Report

    FavorávelMetanáliseEfeitos Adversos da Cannabis
  123. 2017

    Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series

    InconclusivoMetanáliseCapsaicina (CAPS)
  124. 2016

    An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of Jejunum on the Way to Unravel Her Hyperemesis Enigma

    DesfavorávelMetanáliseTHC Farmacêutico
  125. 2016

    Cannabinoid hyperemesis syndrome

    DesfavorávelMetanáliseTetraidrocanabinol (THC)
  126. 2016

    Cannabinoid hyperemesis syndrome masquerading as an eating disorder

    InconclusivoMetanáliseAnorexia (perda de apetite)
  127. 2016

    Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use

    DesfavorávelMetanálise
  128. 2016

    Cannabinoid hyperemesis syndrome: A review of the literature

    InconclusivoMetanálise
  129. 2016

    Cannabinoid Hyperemesis Syndrome: An Emerging Drug-Induced Disease

    DesfavorávelMetanálise
  130. 2016

    Cannabinoid hyperemesis syndrome. A report of six new cases and a summary of previous reports

    InconclusivoMetanálise
  131. 2016

    Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study

    InconclusivoMetanálise
  132. 2016

    Case Report of Intractable Vomiting and Abdominal Pain Related to Heavy Daily Cannabis Use

    DesfavorávelMetanáliseTetraidrocanabinol (THC)
  133. 2016

    Cyclic vomiting and abdominal pain from prolonged cannabis use

    DesfavorávelMetanálise
  134. 2016

    High prevalence of cannabinoid hyperemesis syndrome in marijuana users

    DesfavorávelMetanálise
  135. 2016

    Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting

    DesfavorávelMetanálise
  136. 2016

    Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure

  137. 2015

    13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire

    InconclusivoMetanáliseNáusea e Vômito
  138. 2015

    A non-classical cannabinoid syndrome

    DesfavorávelMetanálise
  139. 2015

    Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse

    DesfavorávelMetanálise
  140. 2015

    Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent

    DesfavorávelMetanálise
  141. 2015

    Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review

    DesfavorávelMetanálise
  142. 2015

    Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy

    DesfavorávelMetanáliseGestação
  143. 2015

    Cannabinoid hyperemesis syndrome: a guide for the practicing clinician

    DesfavorávelMetanálise
  144. 2015

    Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect

    DesfavorávelMetanálise
  145. 2015

    Cannabinoid hyperemesis syndrome: about 6 cases

    DesfavorávelMetanáliseNáusea e Vômito
  146. 2015

    Cannabinoid hyperemesis syndrome: an important differential diagnosis of persistent unexplained vomiting

    DesfavorávelMetanálise
  147. 2015

    Cannabis hyperemesis syndrome: A case report review of treatment

    DesfavorávelMetanálise
  148. 2015

    Diagnosing and treating cannabinoid hyperemesis

    InconclusivoMetanálise
  149. 2014

    A Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  150. 2014

    A rare case of cannabis hyperemesis syndrome relieved by hot water bathing

    DesfavorávelMetanálise
  151. 2014

    Cannabinoid hyperemesis syndrome should be considered by recurrent vomiting

    InconclusivoMetanálise
  152. 2014

    Cannabinoid Hyperemesis Syndrome: A Case Report and Review of Pathophysiology

    DesfavorávelMetanálise
  153. 2014

    Case of cannabinoid hyperemesis syndrome with long-term follow-up

    DesfavorávelMetanálise
  154. 2014

    Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)
  155. 2014

    Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting

    FavorávelMetanáliseNáusea e VômitoTHC Farmacêutico
  156. 2014

    No opiates against cannabis hyperemesis syndrome

    DesfavorávelMetanáliseDependência — Opioides
  157. 2014

    Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome

  158. 2013

    A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids

  159. 2013

    Cannabinoid Hyper-emesis Syndrome: An Enigma

    DesfavorávelMetanálise
  160. 2013

    Cannabinoid Hyperemesis Syndrome

    DesfavorávelMetanáliseNáusea e VômitoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  161. 2013

    Cannabinoid Hyperemesis Syndrome

    DesfavorávelMetanálise
  162. 2013

    Compulsive showering and marijuana use – the cannabis hyperemisis syndrome

    DesfavorávelMetanálise
  163. 2012

    Association of Marijuana Use and Cyclic Vomiting Syndrome

    DesfavorávelMetanáliseNáusea e Vômito
  164. 2012

    Cannabinoid Hyperemesis

    DesfavorávelMetanálise
  165. 2012

    Cannabinoid hyperemesis syndrome: a case series and review of previous reports

    DesfavorávelMetanáliseNáusea e Vômito
  166. 2012

    Cannabinoid Hyperemesis: A Case Series of 98 Patients

    DesfavorávelMetanálise
  167. 2012

    Cannabis hyperemesis syndrome

    DesfavorávelMetanálise
  168. 2012

    Cannabis—A Valuable Drug That Deserves Better Treatment

  169. 2012

    Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerEsclerose MúltiplaTHC Farmacêutico+3
  170. 2011

    Cannabinoid hyperemesis syndrome

    DesfavorávelMetanálise
  171. 2011

    Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting

    DesfavorávelMetanálise
  172. 2011

    Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance

    DesfavorávelMetanáliseInsuficiência Renal
  173. 2011

    Cannabinoid-induced hyperemesis

    DesfavorávelMetanálise
  174. 2011

    Hyperemesis and a high water bill

    DesfavorávelMetanálise
  175. 2010

    Cannabinoid hyperemesis

    DesfavorávelMetanálise
  176. 2010

    Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms

    DesfavorávelMetanálise
  177. 2010

    Cannabis and hyperemesis

    DesfavorávelMetanálise
  178. 2010

    Pediatric cannabinoid hyperemesis: two cases

    DesfavorávelMetanálise
  179. 2010

    The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States

    DesfavorávelMetanálise
  180. 2009

    Cannabinoid hyperemesis presenting to a New Zealand hospital

    DesfavorávelMetanálise
  181. 2009

    Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognized manifestation of chronic cannabis abuse

    DesfavorávelMetanálise
  182. 2009

    Cyclical hyperemesis secondary to cannabis abuse

    DesfavorávelMetanálise
  183. 2005

    Cannabinoid hyperemesis with the unusual symptom of compulsive bathing

    DesfavorávelMetanálise
  184. 2004

    Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse

    DesfavorávelMetanáliseNáusea e Vômito

Continue por aqui

Perguntas frequentes

Quantos estudos sobre síndrome da hiperêmese canabinoide estão indexados no acervo?
São 184 estudos, publicados entre 2004 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 176 · Ensaio Clínico: 4 · Ensaio Clínico Duplo-Cego: 3 · Metanálise Clínica: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 19 favoráveis, 44 inconclusivos e 121 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Síndrome da Hiperêmese Canabinoide — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/sindrome-da-hiperemese-canabinoide/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Síndrome da Hiperêmese Canabinoide — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/sindrome-da-hiperemese-canabinoide/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.